Supporting the best innovations to address the global threat of AMR
We are supporting a diverse portfolio of projects aimed at developing new tests and treatments for bacterial infections with high unmet need. Through a series of funding rounds available to academics and SMEs worldwide, we are selecting, investing in and supporting the most promising projects. We are offering a collaborative approach to project development through access to advisors, mentors, potential project partners and enabling technologies and capabilities. By supporting the projects in this way, we are helping to give them the best chance of success and position them for onward funding, investment and development. More projects will enter the portfolio as the programme progresses. This page highlights the innovators and projects that are currently in the PACE portfolio.
Project title: DOSA point-of-care diagnostic for urinary tract infections in low- and middle-income countries (DOSA3)
Project title: Novltex: A dual-mechanism macrocyclic antibiotic for intravenous and inhaled treatment of carbapenem- and polymyxin-resistant Acinetobacter baumannii (CRAB) pneumonia
Project title: Development of anti-infective conjugated electrolytes (ACEs) as a novel class of antibiotic